196 related articles for article (PubMed ID: 16459182)
1. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents.
Araki H; Mahmud N; Milhem M; Nunez R; Xu M; Beam CA; Hoffman R
Exp Hematol; 2006 Feb; 34(2):140-9. PubMed ID: 16459182
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers.
Saraf S; Araki H; Petro B; Park Y; Taioli S; Yoshinaga KG; Koca E; Rondelli D; Mahmud N
Transfusion; 2015 Apr; 55(4):864-74. PubMed ID: 25363624
[TBL] [Abstract][Full Text] [Related]
3. Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues.
Araki H; Baluchamy S; Yoshinaga K; Petro B; Petiwala S; Parajuli R; Milhem M; Lavelle D; DeSimone J; Mahmud N
Exp Hematol; 2009 Sep; 37(9):1084-95. PubMed ID: 19501128
[TBL] [Abstract][Full Text] [Related]
4. Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential.
Araki H; Yoshinaga K; Boccuni P; Zhao Y; Hoffman R; Mahmud N
Blood; 2007 Apr; 109(8):3570-8. PubMed ID: 17185465
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells.
Mahmud N; Petro B; Baluchamy S; Li X; Taioli S; Lavelle D; Quigley JG; Suphangul M; Araki H
Biol Blood Marrow Transplant; 2014 Apr; 20(4):480-9. PubMed ID: 24374212
[TBL] [Abstract][Full Text] [Related]
6. In vitro expanded cells contributing to rapid severe combined immunodeficient repopulation activity are CD34+38-33+90+45RA-.
Vanheusden K; Van Coppernolle S; De Smedt M; Plum J; Vandekerckhove B
Stem Cells; 2007 Jan; 25(1):107-14. PubMed ID: 16973833
[TBL] [Abstract][Full Text] [Related]
7. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.
Wang X; Zhang W; Tripodi J; Lu M; Xu M; Najfeld V; Li Y; Hoffman R
Blood; 2010 Dec; 116(26):5972-82. PubMed ID: 20858855
[TBL] [Abstract][Full Text] [Related]
8. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
Kusadasi N; van Soest PL; Mayen AE; Koevoet JL; Ploemacher RE
Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
[TBL] [Abstract][Full Text] [Related]
9. Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood.
Zhang XB; Li K; Fok TF; Li CK; James AE; Lam AC; Lee SM; Yuen PM
Bone Marrow Transplant; 2002 Nov; 30(9):557-64. PubMed ID: 12407429
[TBL] [Abstract][Full Text] [Related]
10. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
11. Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis.
Shi J; Zhao Y; Ishii T; Hu W; Sozer S; Zhang W; Bruno E; Lindgren V; Xu M; Hoffman R
Cancer Res; 2007 Jul; 67(13):6417-24. PubMed ID: 17616702
[TBL] [Abstract][Full Text] [Related]
12. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
Madlambayan GJ; Rogers I; Purpura KA; Ito C; Yu M; Kirouac D; Casper RF; Zandstra PW
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
[TBL] [Abstract][Full Text] [Related]
13. Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents.
Wang X; Zhang W; Ishii T; Sozer S; Wang J; Xu M; Hoffman R
Cancer Res; 2009 Oct; 69(19):7612-8. PubMed ID: 19752087
[TBL] [Abstract][Full Text] [Related]
14. Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures.
Ong LM; Fan X; Chu PP; Gay FP; Bari S; Ang JM; Li Z; Chen J; Lim SK; Bunte RM; Hwang WY
Biol Blood Marrow Transplant; 2012 May; 18(5):674-82. PubMed ID: 22240732
[TBL] [Abstract][Full Text] [Related]
15. Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions.
Gunetti M; Ferrero I; Rustichelli D; Berger M; Gammaitoni L; Timeus F; Piacibello W; Aglietta M; Fagioli F
Exp Hematol; 2008 Feb; 36(2):235-43. PubMed ID: 18206730
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
[TBL] [Abstract][Full Text] [Related]
17. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
[TBL] [Abstract][Full Text] [Related]
18. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
19. Co-culture of human CD34+ cells with mesenchymal stem cells increases the survival of CD34+ cells against the 5-aza-deoxycytidine- or trichostatin A-induced cell death.
Koh SH; Choi HS; Park ES; Kang HJ; Ahn HS; Shin HY
Biochem Biophys Res Commun; 2005 Apr; 329(3):1039-45. PubMed ID: 15752760
[TBL] [Abstract][Full Text] [Related]
20. HOX decoy peptide enhances the ex vivo expansion of human umbilical cord blood CD34+ hematopoietic stem cells/hematopoietic progenitor cells.
Tanaka H; Matsumura I; Itoh K; Hatsuyama A; Shikamura M; Satoh Y; Heike T; Nakahata T; Kanakura Y
Stem Cells; 2006 Nov; 24(11):2592-602. PubMed ID: 17071861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]